By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kyowa Hakko Kirin 

Ohtemachi Building 5F
1-6-1 Ohtemachi, Chiyoda-ku
Tokyo    100-8185  Japan
Phone: 81-3-3282-0007 Fax: 81-3-3284-1968


SEARCH JOBS


Industry
Biotechnology






Company News
ArQule, Inc. (ARQL) Announces Commencement Of Phase 3 Clinical Trial With Tivantinib In Hepatocellular Carcinoma By Partner Kyowa Hakko Kirin In Japan 2/4/2014 9:46:24 AM
The NovAliX/Kyowa Hakko Kirin Alliance Will Commence A Fragment-Based Drug Discovery Project Targeting An Important Protein/Protein Interaction 11/18/2013 10:49:47 AM
Ultragenyx Pharmaceuticals Announces the Presentation of Data From a Single Dose Phase 1 Study, Conducted by Kyowa Hakko Kirin, of KRN23 in X-linked Hypophosphatemia (XLH) in Adults 10/7/2013 9:45:31 AM
Abstral® , Manufactured and Packaged by Recipharm AB for Kyowa Hakko Kirin, Has Been Approved in Japan 9/23/2013 8:22:40 AM
Activiomics Extends Research Agreement With Kyowa Hakko Kirin as Part of Its Strategic Partnership With BioFocus DPI 9/19/2013 9:40:30 AM
Ultragenyx Pharmaceuticals Announces Collaboration With Kyowa Hakko Kirin to Develop and Commercialize Phase 2-Stage KRN23 for X-Linked Hypophosphatemia 9/4/2013 12:46:21 AM
La Jolla Institute for Allergy and Immunology Continues Longtime Collaboration With Kyowa Hakko Kirin 8/1/2013 10:35:22 AM
Ezose Sciences, Inc. Enters Glycomics Research Agreement With Kyowa Hakko Kirin 1/28/2013 2:14:47 PM
NovAliX Enters Into Fragment-Based Drug Discovery Alliance With Kyowa Hakko Kirin 1/14/2013 11:00:24 AM
Adimab LLC. Announces New Discovery Collaboration ith Kyowa Hakko Kirin 1/7/2013 10:23:38 AM
123
//-->